Note 5 - Inventories

12 Months Ended

Dec. 31, 2020

Notes to Financial Statements

Inventory Disclosure [Text Block]

5. Inventories

Inventories consist of the following:

	December 31,
	2020		2019
Raw materials	$	14,852	$	12,058
Work-in-process		12,811		8,330
Finished goods		33,347		8,777
Total	$	61,010	$	29,165
Inventories	$	46,209	$	21,995
Other long-term assets		14,801		7,170

Inventory is stated net of inventory reserves of approximately $6.9 million and $3.0 million, as of December 31, 2020 and 2019, respectively.

The increase in inventories for the year ended December 31, 2020 is primarily due to the acquisitions of Parcus Medical and Arthrosurface in January and February 2020, as discussed in Note 3 – Business Combinations.

The Company recorded an inventory reserve of $2.8 million in 2020 as a result of the Company's product rationalization efforts, including a decision about not to pursue CE mark renewals for certain legacy products, primarily for certain advanced wound care products which will not be sold prior to expiration of the applicable CE mark based on current projections.